Authors
Man, Nicola ; https://orcid.org/0000-0003-2224-9301Sadaphale, VanditYang, YanBruno, Raimondo ; https://orcid.org/0000-0001-6673-833XBarratt, Monica ; https://orcid.org/0000-0002-1015-9379Sutherland, Rachel ; https://orcid.org/0000-0001-5337-1751Peacock, Amy ; https://orcid.org/0000-0002-5705-2026
Topics
Pharmaceutical Quality and CounterfeitingSocial Media in Health EducationPharmacovigilance and Adverse Drug ReactionsAuthor:Man, Nicola; Sadaphale, Vandit; Yang, Yan; Bruno, Raimondo; Barratt, Monica;Sutherland, Rachel; Peacock, AmyPublication Date:2024-03-28License:https://creativecommons.org/licenses/by/4.0/Link to license to see what you are allowed to do with this resource.Downloaded from http://hdl.handle.net/1959.4/unsworks_85788 in https://unsworks.unsw.edu.au on 2026-01-10Last update: 23 November 2023Nicola Man, Vandit Sadaphale, Yan Yang, Raimondo Bruno, Monica J. Barratt, Rachel Sutherland and Amy Peacock This report was prepared by the National Drug and Alcohol Research Centre, UNSW Sydney For further information: drugtrends@unsw.edu.au stFebruary 2023 to 31 stJanuary 2024, 16 cryptomarkets were monitored, of which 11 remained active at the end of the reporting period.• The three markets reaching more than 10,000 listings in a snapshot during this period were Bohemia, ASAP and Incognito.• In the final month of monitoring, Incognito, Bohemia, Nemesis and Archetyp were the largest cryptomarkets.• There was an average of 42,008 drug listings per snapshot in January 2024, with an estimated decrease in listings of -1.9% per month as compared to February 2023 (n=49,571), although new markets identified subsequently may offset this decline.• Cannabis comprised the greatest percentage of drug listings from February 2023 to January 2024 (29%), followed by MDMA (8.0%), benzodiazepines (7.6%), cocaine (7.3%), opioids (excluding heroin) (6.2%), and meth/amphetamine (illicit) (5.8%).• The market share of opioids (excluding heroin) showed the highest rate of increase from 5.2% in February 2023 to 6.8% in January 2024. Cannabis was the only drug class with a significant rate of decrease in market share, from 32% in February 2023 to 28% in January 2024.Figure 1. Word cloud of cryptomarkets monitored from February 2023 to January 2024.Note: The five cryptomarkets that closed before the end of January 2024 are in grey color font. The maximum size of the market (in the period from February 2023 to January 2024 as shown in Table 1) is proportional to the font size of the cryptomarket.KEY FINDINGS 2BACKGROUND 50BPanel A. Terminology 5FINDINGS 7Profile of Cryptomarkets from 1stFebruary 2023 to 31 stJanuary 2024 7 Which markets were monitored during this period? 7 Which markets closed during this period? 7 What markets were monitored for the first time during this period? 9 Which markets from this period have been monitored for the longest? 9 Which markets from this period were the largest in size based on number of drug listings? 10 Did the total market size (based on number of drug listings in the 16 monitored markets) change over this period? 10 Did the size of the individual markets change over the period? 12 Main Drugs Sold via Cryptomarkets from 1stFebruary 2023 to 31 stJanuary 2024 13 What were the main drugs sold via cryptomarkets during this period? 13 Did the market share of the main drugs sold via cryptomarkets change over this period? 13 Did the market size (based on the number of listings) of the main drugs sold via cryptomarkets change over this period? 15 What drugs did the different markets sell over this period? 17 Funding and Copyright 21 Recommended Citation 21 Acknowledgements 21 Related Links 21Figure 1. Word cloud of cryptomarkets monitored from 1 stFebruary 2023 to 31 stJanuary 2024..........................2Figure 2. Markets monitored from 1stFebruary 2023 to 31 stJanuary 2024.....................................................................8Figure 3. Number of drug listings by marketplace from 1 stFebruary 2023 to 31 stJanuary 2024........................ 11Figure 4. Percentage breakdown of listings by month and drug class over time from 1 stFebruary 2023 toJanuary 2024................................................................................................................................................................................. 15Table 1. Characteristics of markets identified in this bulletin (ordered by date of first snapshot). ........................9Table 2. Number of drug listings (including interpolated data for missing scrapes) and average monthly percent change (AMPC in %) on the markets monitored from 1 stFebruary 2023 to 31 stJanuary 2024........... 12Table 3. Market share (percentage of listings) by drug class, and their average monthly percent change (AMPC in %) from 1 stFebruary 2023 to 31 stJanuary 2024................................................................................................................. 14Table 4. Market size (number of listings) by drug class and their average monthly percent change (AMPC in %) from 1 stFebruary 2023 to 31 stJanuary 2024...................................................................................................................... 17Table 5. Relative percent difference in drug market share between each market and the overall market from 1February 2023 to 31 stJanuary 2024. ...................................................................................................................................... 20
About
PublishedMar 28, 2024
TypeReport
Citations0